About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Glatiramer
- Procedure number
- PSUSA/00001529/202011
- Regulatory outcome
- Variation
Documents
Glatiramer - List of nationally authorised medicinal products - PSUSA-00001529-202011
English (EN) (262.84 KB - PDF)
Glatiramer - Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation - PSUSA-00001529-202011
English (EN) (33.83 KB - PDF)
български (BG) (80.29 KB - PDF)
español (ES) (35.56 KB - PDF)
čeština (CS) (134.01 KB - PDF)
dansk (DA) (34.48 KB - PDF)
Deutsch (DE) (155.78 KB - PDF)
eesti keel (ET) (30.2 KB - PDF)
ελληνικά (EL) (84.1 KB - PDF)
français (FR) (34.28 KB - PDF)
hrvatski (HR) (73.59 KB - PDF)
íslenska (IS) (36.15 KB - PDF)
italiano (IT) (36.54 KB - PDF)
latviešu valoda (LV) (76.32 KB - PDF)
lietuvių kalba (LT) (77.31 KB - PDF)
magyar (HU) (153.76 KB - PDF)
Malti (MT) (78.4 KB - PDF)
Nederlands (NL) (36.33 KB - PDF)
norsk (NO) (30.64 KB - PDF)
polski (PL) (80.05 KB - PDF)
português (PT) (34.25 KB - PDF)
română (RO) (66.96 KB - PDF)
slovenčina (SK) (77.46 KB - PDF)
slovenščina (SL) (66.22 KB - PDF)
Suomi (FI) (86.42 KB - PDF)
svenska (SV) (34.46 KB - PDF)